A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium. [electronic resource]
Producer: 20000829Description: 197-205 p. digitalISSN:- 0014-2999
- Animals
- Cell Adhesion -- drug effects
- Cell Degranulation -- drug effects
- Coronary Vessels -- drug effects
- Dogs
- Dose-Response Relationship, Drug
- Endothelium, Vascular -- drug effects
- Female
- Imidazoles -- pharmacology
- In Vitro Techniques
- Male
- Neutrophil Activation -- drug effects
- Neutrophils -- cytology
- Pyridines -- pharmacology
- Quinazolines -- pharmacology
- Superoxides -- metabolism
- Triazines -- pharmacology
- Triazoles -- pharmacology
- Vasodilation -- drug effects
- Xanthines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.